Request Deal Involvement

OrbiMed and SR One led a $60m Series B round in Avenzo Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Principals

LILLY ASIA VENTURES

bidder

LILLY ASIA VENTURES

DELOS CAPITAL

bidder

DELOS CAPITAL

INCE CAPITAL

bidder

INCE CAPITAL

AVENZO THERAPEUTICS

target

AVENZO THERAPEUTICS

FORESITE CAPITAL MANAGEMENT LLC

bidder

FORESITE CAPITAL MANAGEMENT LLC

TF CAPITAL

bidder

TF CAPITAL

ORBIMED ADVISORS LLC

bidder

ORBIMED ADVISORS LLC

SR ONE CAPITAL MANAGEMENT

bidder

SR ONE CAPITAL MANAGEMENT

LONGWOOD FUND

bidder

LONGWOOD FUND

SURVEYOR CAPITAL

bidder

SURVEYOR CAPITAL

NEW ENTERPRISE ASSOCIATES (NEA)

bidder

NEW ENTERPRISE ASSOCIATES (NEA)

DEEP TRACK CAPITAL

bidder

DEEP TRACK CAPITAL

SOFINNOVA INVESTMENTS

bidder

SOFINNOVA INVESTMENTS

SANDS CAPITAL

bidder

SANDS CAPITAL

QUAN CAPITAL

bidder

QUAN CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite